Investors

Overview

OpGen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. We are developing molecular information products and services for global healthcare settings, helping to guide clinicians with more rapid and actionable information about life threatening infections, improve patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms, or MDROs.

Shareholder Tools

Latest News
11.19.19
OpGen Products in Development to Address “Urgent Threat” Pathogens Highlighted in New CDC Report on Antibiotic Resistance Threats
11.06.19
OpGen Reports Third Quarter 2019 Financial Results and Provides Business Update
11.04.19
OpGen Provides Update on Curetis Group Company Ares Genetics Business

btn News

See All News

Upcoming Events
More events are coming soon.

btn Events

See all events